316
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

In silico screening of natural compounds to inhibit interaction of human ACE2 receptor and spike protein of SARS-CoV-2 for the prevention of COVID-19

, , , , , , ORCID Icon & show all
Pages 646-658 | Received 24 Jan 2021, Accepted 21 Nov 2021, Published online: 02 Dec 2021

References

  • Aniyery, R. B., Sharma, A., & Gupta, A. (2015). Molecular docking studies and in silico pharmacokinetic property study of synthesized organotin complex of (1r, 2s, 5r)-2-isopropyl-5-methylcyclohexanol. Journal of Chemical and Pharmaceutical Sciences, 9(4), 2656–2663.
  • Bloom, D. E., & Cadarette, D. (2019). Infectious disease threats in the twenty-first century: Strengthening the global response. Frontiers in Immunology, 10, 549.
  • Grüber, C., Keil, T., Kulig, M., Roll, S., Wahn, U., & Wahn, V., the MAS-90 Study Group. (2008). History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatric Allergy and Immunology, 19(6), 505–512. https://doi.org/10.1111/j.1399-3038.2007.00688.x
  • Guengerich, F. (2003). Cytochromes P450, drugs, and diseases. Molecular Interventions, 3(4), 194–204. https://doi.org/10.1124/mi.3.4.194
  • Hajivalili, M., Hosseini, M., & Haji-Fatahaliha, M. (2020). Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges. Life Sciences, 257(118058), 118058.
  • Hassan, A. E. (2021). An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting. Annals of Medicine and Surgery), 68, 102574. https://doi.org/10.1016/j.amsu.2021.102574
  • Hofmann, H., Krzysztof, P., van der Hoek, L., Geier, M., Berkhout, B., & Pohlmann, S. (2005). Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proceedings of the National Academy of Sciences, USA, 102, 7988–7993.
  • Huang, R. L., Huang, Y. L., Ou, J. C., Chen, C. C., Hsu, F. L., & Chang, C. (2003). Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro. Phytotherapy Research: PTR, 17(5), 449–453.
  • Jaimes, J. A., Millet, J. K., Stout, A. E., Andre, N. M., & Whittaker, G. R. (2020). A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses, 12(1), 83.
  • Jia, H. P., Look, D. C., Shi, L., Hickey, M., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S., & McCray, P. B. (2005). ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of Virology, 79(23), 14614–14621. https://doi.org/10.1128/JVI.79.23.14614-14621.2005
  • Khan, S. A., & Al-Balushi, K. (2021). Combating COVID-19: The role of drug repurposing and medicinal plants. Journal of Infection and Public Health, 14(4), 495–503. https://doi.org/10.1016/j.jiph.2020.10.012
  • Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M. … Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
  • Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249.
  • Martin, Y. C. (2005). A bioavailability score. Journal of Medicinal Chemistry, 48(9), 3164–3170. https://doi.org/10.1021/jm0492002
  • McCarty, M. F., O'Keefe, J. H., & DiNicolantonio, J. J. (2019). Glucosamine for the treatment of osteoarthritis: The time has come for higher-dose trials. Journal of Dietary Supplements, 16(2), 179–192. https://doi.org/10.1080/19390211.2018.1448920
  • Nisha, C., Kumar, A., Vimal, A., Bai, B., Pal, D., & Kumar, A. (2016). Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor. Journal of Molecular Graphics & Modelling, 65, 100–107.
  • Nutho, B., Mahalapbutr, P., Hengphasatporn, K., Pattaranggoon, N. C., Simanon, N., Shigeta, Y., Hannongbua, S., & Rungrotmongkol, T. (2020). Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms. Biochemistry, 59(18), 1769–1779.
  • O'Boyle, N., Banck, M., James, C., Morley, C., Vandermeersch, T., & Hutchison, G. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33.
  • Padhi, A. K., Seal, A., Khan, J. M., Ahamed, M., & Tripathi, T. (2021). Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations. European Journal of Pharmacology, 894, 173836. https://doi.org/10.1016/j.ejphar.2020.173836
  • Parle, M., & Bansal, N. (2006). Traditional medicinal formulation, Chyawanprash – A review. Indian Journal Traditional Knowledge, 5, 484–488.
  • Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (Oxford, England), 29(7), 845–854.
  • Purohit, R., Rajendran, V., & Sethumadhavan, R. (2011). Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants. Journal of Biomolecular Structure & Dynamics, 29(1), 137–152.
  • Purohit, R., & Sethumadhavan, R. (2009). Structural basis for the resilience of darunavir (TMC114) resistance major flap mutations of HIV-1 protease. Interdisciplinary Sciences, Computational Life Sciences, 1(4), 320–328.
  • Sharma, A., Vora, J., Patel, D., Sinha, S., Jha, P. C., & Shrivastava, N. (2020). Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches. Journal of Biomolecular Structure and Dynamics, 1–16.
  • Singh, J., Sinha, K., Sharma, A., Mishra, N. P., & Khanuja, S. P. (2003). Traditional uses of Tinospora cordifolia (Guduchi). Journal of Medicinal Aromatic Plant Science, 25, 748–751.
  • Towler, P., Staker, B., Prasad, S. G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N. A., Patane, M. A., & Pantoliano, M. W. (2004). ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. Journal of Biological Chemistry, 279(17), 17996–18007. https://doi.org/10.1074/jbc.M311191200
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461.
  • Verma, K., Kannan, K., Shanthi, V., Sethumadhavan, R., Karthik, V., & Ramanathan, K. (2017). Exploring beta-tubulin inhibitors from plant origin using computational approach. Phytochemical Analysis : PCA, 28(3), 230–241.
  • Wan, Y., Shang, J., Graham, R., & Baric, R. S. (2020). Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. Coronavirus. Journal of Virology, 94(7).
  • Wang, W., Tang, J., & Wei, F. (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan. Journal of Medical Virology, 92(4), 441–447. https://doi.org/10.1002/jmv.25689
  • Wen, C.-C., Kuo, Y.-H., Jan, J.-T., Liang, P.-H., Wang, S.-Y., Liu, H.-G., Lee, C.-K., Chang, S.-T., Kuo, C.-J., Lee, S.-S., Hou, C.-C., Hsiao, P.-W., Chien, S.-C., Shyur, L.-F., & Yang, N.-S. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. Journal of Medicinal Chemistry, 50(17), 4087–4095.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.